HALO · Halozyme Therapeutics, Inc. · Investor Relations
$93.19
-2.61 (-2.72%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$10.57B
Shares
114.01M
Volume · Nov 19
750.48K
Avg daily vol (3M)
2.24M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
Past events
Key facts
CIK
1159036
CUSIP
40637H109
13F (30d)
736 filings
687 filers
Visit website
Investor relations